%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-08-01T19:02:50+03:00
2013-08-01T19:02:50+03:00
2013-08-01T19:02:50+03:00
application/pdf
bs-1712R-Biotin
uuid:b67327b3-b189-4da7-995c-6a92c95cc0de
uuid:710bce65-7b71-487b-a53e-c3c5cb2782fb
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[31 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.726 574.5 -735.891 re
f
BT
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 21.2908 767.2422 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw 0 -1.5 TD
[(800.501.7654)-34( )1([DOMESTIC])]TJ
0 -1.5 TD
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
141.4664764 0 0 -79.6994171 439.7127228 810.412735 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 9.2983 0 0 9.2983 21.2908 715.4376 Tm
[(bs)-67(-)-69(1712R)-12(-)-69(Biotin)]TJ
/TT0 1 Tf
-0.04 Tw 7.3058 0 0 7.3058 22.6191 658.3196 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Cytokeratins,)-63( a)-20( group)-69( comprising)-46( at)-50( least)-31( 29)-90( different)-5( proteins,)-57( are)-44( characteristic)-9( of)-48( epithelial)-62( and trichocytic)]TJ
0 -1.455 TD
[(cells.)-79( Cytokeratins)-3( 1,)-60( 4,)-60( 5,)-60( 6,)-60( and 8)-90( are)-44( members)-91( of)-48( the)-37( type)-89( II)-72( neutral)-1( to)-32( basic)-59( subfamily.)-46( Monoclonal)-40( anti)]TJ
0 -1.455 TD
[(cytokeratins)-52( are)-44( specific)-50( markers)-81( of)-48( epithelial)-62( cell)-9( differentiation)-42( and have)-75( been)-19( widely)-41( used)-8( as)-29( tools)-87( in)-31( tumor)]TJ
T*
[(identification)-10( and classification.)-73( Monoclonal)-40( Anti)-6( Pan)-2( Cytokeratin)-85( \(mixture\))-74( is)-52( a)-20( broadly)-12( reactive)-86( reagent,)-42( which)]TJ
0 -1.455 TD
[(recognizes)-81( epitopes)-17( present)-61( in)-31( most)-19( human)-52( epithelial)-62( tissues.)-76( It)-20( facilitates)-26( typing)-2( of)-48( normal,)-6( metaplastic)-89( and)]TJ
0 -1.455 TD
[(neoplastic)-50( cells.)-79( Synergy)-86( between)-53( the)-36( various)-23( components)-2( results)-10( in)-31( staining)-22( amplification.)-33( This)-1( enables)]TJ
0 -1.455 TD
[(identification)-10( of)-48( cells,)-79( which)-88( would)-11( otherwise)-9( be)-12( stained)-11( only)-81( marginally.)-60( The)-59( mixture)-22( may)-46( aid)-57( in)-31( the)]TJ
0 -1.455 TD
[(discrimination)-88( of)-48( carcinomas)-52( and nonepithelial)-39( tumors)-10( such)-68( as)-29( sarcomas,)-5( lymphomas)-59( and neural)-62( tumors.)-70( It)-20( is)]TJ
T*
[(also)-75( useful)-1( in)-31( detecting)-17( micrometastases)-74( in)-31( lymph)-49( nodes,)-71( bone)-2( marrow)-85( and other)-43( tissues)-15( and for)-52( determining)-7( the)]TJ
0 -1.455 TD
[(origin)-73( of)-48( poorly)-1( differentiated)-20( tumors.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
0 Tw -6.727 -2 Td
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Prepared)-46( as)-29( lyophilized)-45( powder)-87( and shipped)-36( on)-81( ice.)-26( Store)-44( at)-50( -)-1(20\260C)-18( for)-52( one)-9( year)-91( as)-29( lyophilized)-45( powder)-87( or)-6( liquid.)]TJ
0 -1.455 TD
[(Please)-15( reconstitute)-64( before)-83( use.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-36( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-37( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-36( package.)]TJ
/TT1 1 Tf
0 Tw 53.545 35.455 Td
(Size:)Tj
/TT0 1 Tf
-0.04 Tw 3 -0.091 Td
[(100ul)-29( or)-6( 100ug)-69( lyophilized)]TJ
/TT1 1 Tf
0 Tw -3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 413.8104 623.1191 Tm
(Human,Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,)Tj
0 scn
/TT1 1 Tf
7.3058 0 0 7.3058 413.8104 609.1717 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 423.7728 591.5714 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.3058 0 0 7.3058 430.4145 589.911 Tm
[(ELISA\(1:500)-35(-)-1(1000\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 423.7728 580.9448 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.3058 0 0 7.3058 430.4145 579.2844 Tm
[(IHC)-78(-)-1(P\(1:100)-73(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 423.7728 570.3182 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.3058 0 0 7.3058 430.4145 568.6578 Tm
[(IHC)-78(-)-1(F\(1:100)-13(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 423.7728 559.6917 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 7.3058 0 0 7.3058 430.4145 558.0312 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)-57( Optimal)]TJ
T*
[(working)-62( dilutions)-48( must)-4( be)-12( determined)-86( by)]TJ
0 -1.455 TD
[(the)-36( end)-90( user.)]TJ
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 456.9809 494.2717 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 7.3058 0 0 7.3058 413.8104 480.3243 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.6416 0 0 6.6416 492.8457 480.3243 Tm
[(42)-8(-)-37(64kDa)]TJ
0 scn
/TT1 1 Tf
7.3058 0 0 7.3058 413.8104 466.3769 Tm
(Preservatives:)Tj
0.2 scn
/TT0 1 Tf
-0.012 Tw 6.6416 0 0 6.6416 478.2341 466.3769 Tm
[(10ug/uL)-59( )1(BSA)-54( )1(and)-64( )1(0.1%)-28( )1(NaN3.)]TJ
0 scn
0.021 Tw 5.9775 0 0 5.9775 413.8104 439.1462 Tm
[(For)-20( )1(research)-16( )1(use)-25( )1(only.)-91( )1(CAUTION:)-13( )1(Not)-12( )1(for)-1( )1(human)-72( )1(or)]TJ
0 -1.333 TD
[(animal)-94( )1(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
564.5375671 0 0 -0.6641693 15.9774628 706.8034821 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.6266 0 0 10.6266 15.3133 81.8272 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 13.3208 691.5278 cm
0 0 m
0 1.771 -2.657 1.771 -2.657 0 c
-2.657 -1.771 0 -1.771 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/TT1 1 Tf
-0.007 Tw 9.2983 0 0 9.2983 22.6191 688.8711 Tm
[(Rabbit)-50( Anti)-28(-)-69(P)-57(-)-69(CK/Cytokeratin)-53( AE1)-63( +)-39( AE3)-63( Polyclonal)-4( Antibody,)-47( Biotin)]TJ
0 Tw 0 -1.143 TD
(conjugated)Tj
ET
q
/GS0 gs
99.6242828 0 0 -75.050293 19.2982635 395.3115692 cm
/Im2 Do
Q
BT
/CS0 cs 0 scn
/TT0 1 Tf
10.6266 0 0 10.6266 19.2983 310.963 Tm
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-24 -2.25 Td
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-24 -2.25 Td
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-0.04 Tw 7.3058 0 0 7.3058 20.6266 231.2636 Tm
[(For)-30( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.6416 0 0 6.6416 174.7121 231.2636 Tm
(HERE)Tj
/CS0 cs 0 scn
7.3058 0 0 7.3058 191.3162 231.2636 Tm
(.)Tj
ET
q
/GS0 gs
0.6641693 0 0 -597.7456512 401.19133 706.1392975 cm
/Im3 Do
Q
q
/GS0 gs
5.9774628 0 0 -40.5138702 575.2017365 120.3485565 cm
/Im4 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
(iRb;QDv\))
endobj
26 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L